Related Experiment Video
Updated: Jan 25, 2026

Author Spotlight: Advancing Gene Editing in Bamboo Leaves for Sustainable Plastic Alternatives
Published on: August 18, 2023
Gene Therapy Leaves a Vicious Cycle
Reena Goswami1, Gayatri Subramanian2, Liliya Silayeva1
1Neuroscience Branch, Research Division, United States Army Medical Research Institute of Chemical Defense, Aberdeen, MD, United States.
Abstract:
The human genetic code encrypted in thousands of genes holds the secret for synthesis of proteins that drive all biological processes necessary for normal life and death. Though the genetic ciphering remains unchanged through generations, some genes get disrupted, deleted and or mutated, manifesting diseases, and or disorders. Current treatment options-chemotherapy, protein therapy, radiotherapy, and surgery available for no more than 500 diseases-neither cure nor prevent genetic errors but often cause many side effects. However, gene therapy, colloquially called "living drug," provides a one-time treatment option by rewriting or fixing errors in the natural genetic ciphering. Since gene therapy is predominantly a viral vector-based medicine, it has met with a fair bit of skepticism from both the science fraternity and patients. Now, thanks to advancements in gene editing and recombinant viral vector development, the interest of clinicians and pharmaceutical industries has been rekindled. With the advent of more than 12 different gene therapy drugs for curing cancer, blindness, immune, and neuronal disorders, this emerging experimental medicine has yet again come in the limelight. The present review article delves into the popular viral vectors used in gene therapy, advances, challenges, and perspectives.
Insights
Gene therapy offers a one-time fix for genetic disorders by correcting errors in DNA. Recent advances in gene editing and viral vectors are revitalizing this "living drug" approach for various diseases.
Area of Science:
- Genetics
- Molecular Biology
- Biotechnology
Background:
- Genetic mutations cause diseases, and current treatments are limited and often cause side effects.
- Gene therapy, a "living drug," aims to correct genetic errors for a one-time cure.
- Viral vector-based gene therapy has faced skepticism but is regaining interest.
Purpose of the Study:
- To review viral vectors used in gene therapy.
- To discuss advances and challenges in gene therapy.
- To explore future perspectives for gene therapy.
Main Methods:
- Review of current literature on gene therapy.
- Analysis of viral vector technologies.
- Examination of gene editing advancements.
Main Results:
- Gene therapy offers a potential cure for genetic disorders by correcting DNA errors.
- Advancements in gene editing and viral vectors have renewed interest in gene therapy.
- Over 12 gene therapy drugs are now available for conditions like cancer and blindness.
Conclusions:
- Gene therapy is a promising one-time treatment for genetic diseases.
- Continued research in viral vectors and gene editing is crucial.
- Gene therapy holds significant potential for treating a wide range of disorders.
Related Concept Videos
Gene Therapy
Leaving Groups
In general, in a nucleophilic substitution reaction, a nucleophile displaces a functional group, called the leaving group, from the substrate to give a substituted product. A leaving group departs the substrate molecule through heterolytic cleavage, taking the pair of electrons with it to become a relatively stable weak base in the form of an anion or a neutral molecule.
In a...
What are Biogeochemical Cycles?
The Water Cycle
The Citric Acid Cycle
The Phosphorus Cycle

